Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The investigators primary objective is to compare the effectiveness of epsilon-aminocaproic
acid (EACA) and tranexamic acid (TA) in reducing bleeding and transfusion in cardiac surgery,
with the hypothesis that TA is more effective. The investigators also seek to further examine
the clinical benefits and adverse effects profiles of epsilon-aminocaproic acid and
tranexamic acid.